• 1
    Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol 2003; 39 (Suppl. 1): 649.
  • 2
    Euler GL, Wooten KG, Baughman AL, Williams WW. Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission. Pediatrics 2003; 111: 11927.
  • 3
    Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy. J Clin Virol 2004; 29: 21120.
  • 4
    Healy CM, Cafferkey MT, Butler KM, et al. Antenatal hepatitis B screening – is there a need for a national policy? Irish Med J 2001; 94: 1112.
  • 5
    Centers for Disease Control. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Recommendations of the Advisory Committee on immunization practices. Part 1: childhood immunization. Morb Mortality Wkly Rep 2005; 54 (RR-16): 132.
  • 6
    Cowan SA, Bagdonaite J, Qureshi K. Universal hepatitis B screening of pregnant women in Denmark ascertains substantial additional infections: results from the first five months. Eurosurveillance 2006; 11: pii2969.
  • 7
    Jonas MM, Schiff ER, O'Sullivan MJ, et al. Failure of the centers for disease control criteria to identify hepatitis B infection in a large municipal obstetrical population. Ann Intern Med 1987; 107: 3357.
  • 8
    Zuckerman J, Van Hattum J, Cafferkey M, et al. Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe? Lancet Infect. Dis 2007; 7: 4109.
  • 9
    Wong S, Chan LY, Yu V, et al. Hepatitis B carrier and perinatal outcome in singleton pregnancy. Am J Perinatol 1999; 16: 4858.
  • 10
    Tse KY, Lo LF, Lao T. The impact of maternal HBsAg carrier status on pregnancy outcomes: a case–control study. J Hepatol 2005; 43: 7715.
  • 11
    Alexander JM, Ramus R, Jackson G, Sercely B, Wendel Jr G. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999; 7: 2836.
  • 12
    Towers CV, Asrat T, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J Obstet Gynecol 2001; 184: 15148.
  • 13
    Söderström A, Norkrans G, Lindh M. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35: 8149.
  • 14
    Lin HH, Chen PJ, Chen DS, et al. Postpartum subsidence of hepatitis B viral replication in HBeAg-positive carrier mothers. J Med Virol 1989; 29: 16.
  • 15
    Lin HH, Wu WY, Kao JH, et al. Hepatitis B post-partum e antigen clearance in hepatitis B carrier mothers: correlation with viral characteristics. J Gastroenterol Hepatol 2006; 21: 6059.
  • 16
    Ter Borg MJ, Leemans WF, De Man RA, Janssen HLA. Exacerbation of chronic hepatitis B infection after delivery. J Vir Hepat 2008; 15: 3741.
  • 17
    Yang Y-B, Li X-M, Shi Z-J, Ma L. Pregnant woman with fulminant hepatic failure caused by hepatitis B virus infection: a case report. World J Gastroenterol 2004; 10: 23056.
  • 18
    Santiago-Munoz P, Roberts S, Sheffield J, McElwee B, Wendel JGD. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus. Am J Obstet Gynecol 2005; 193 (Suppl. 1): 12703.
  • 19
    Cobey FC, Salem RR. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 2004; 187: 18191.
  • 20
    De La Rosa MA, Nicolás-Pérez D, Muñiz-Montes JR, et al. Evolution and management of a hepatocellular carcinoma during pregnancy. J Obstet Gynaecol Res 2006; 32: 4379.
  • 21
    Lau WY, Leung WT, Ho S, et al. Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies. Cancer 1995; 75: 266976.
  • 22
    Gupta I, Ratho RK. Immunogenicity and safety of two schedules of hepatitis B vaccination during pregnancy. J Obstet Gynaecol Res 2003; 29: 846.
  • 23
    Levy M, Koren G. Hepatitis B vaccine in pregnancy: maternal and fetal safety. Am J Perinatol 1991; 8: 22732.
  • 24
    The Antiretroviral Pregnancy Registry Steering Committee. Antiretroviral pregnancy registry international interim report for 1 January 1989 through 31 January 2006. Registry coordinating center; 2006, Wilmington, NC. Report no.:
  • 25
    Su G-G, Pan K-H, Zhao N-F, et al. Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10: 9102.
  • 26
    Xu DZ, Yan YP, Choi BC, et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case–control study. J Med Virol 2002; 67: 206.
  • 27
    Li X-M, Shi M-F, Yang Y-B, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004; 10: 32157.
  • 28
    Bai H, Zhang L, Ma L, et al. Relationship of hepatitis B virus infection of placental barrier and hepatitis B virus intra-uterine transmission mechanism. World J Gastroenterol 2007; 13: 362530.
  • 29
    Lin HH, Lee TY, Chen DS, et al. Transplacental leakage of HBeAg-positive maternal blood as the most likely route in causing intrauterine infection with hepatitis B virus. J Pediatr 1987; 111: 87781.
  • 30
    Zhu QR, Ge YL, Gu SQ, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J 2005; 118: 16049.
  • 31
    Yu H, Zhu QR, Gu SQ, et al. Relationship between IFN-gamma gene polymorphism and susceptibility to intrauterine HBV infection. World J Gastroenterol 2006; 12: 292831.
  • 32
    Lee S-D, Tsai K-S, Wu T-C, et al. Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus. Lancet 1988; 2: 8334.
  • 33
    Wang J, Zhu Q, Zhang X. Effect of delivery mode on maternal–infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J 2002; 115: 15102.
  • 34
    Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 19067.
  • 35
    Chen H-L, Chang C-J, Kong M-S, et al. Pediatric fulminant hepatic failure in endemic areas of hepatitis B infection: 15 years after universal hepatitis B vaccination. Hepatology 2004; 39: 5863.
  • 36
    Lee C, Gong Y, Brok J, Boxall EH, Gluud C. Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ 2006; 332: 32836.
  • 37
    Del Canho R, Grosheide PM, Mazel JA, et al. Ten-year neonatal hepatitis B vaccination program, The Netherlands, 1982–1992: protective efficacy and long-term immunogenicity. Vaccine 1997; 15: 162430.
  • 38
    Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 1999; 30: 13127.
  • 39
    Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet 2000; 355: 13824.
  • 40
    Mele A, Tancredi F, Romano L, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184: 9058.
  • 41
    Xiao XM, Li AZ, Chen X, Zhu YK, Miao J. Prevention of vertical hepatitis B transmission by hepatitis B immunoglobulin in the third trimester of pregnancy. Int J Gynecol Obstet 2007; 96: 16770.
  • 42
    Yuan J, Lin J, Xu A, et al. Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study. J Virol Hepatol 2006; 13: 597604.
  • 43
    Xu Q, Xiao L, Lu X-B, Zhang Y-X, Cai X. A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006; 12: 34347.
  • 44
    Burk RD, Hwang LY, Ho GY, et al. Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load. J Infect Dis 1994; 170: 141823.
  • 45
    Van Zonneveld M, Van Nunen AB, Niesters HGM, et al. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Virol Hepatol 2003; 10: 2947.
  • 46
    Xu WM, Cui YT, Wang L, et al. Efficacy and safety of lamivudine in late pregnancy for the prevention of mother–child transmission of hepatitis B: a multicentre, randomized, double-blind, placebo-controlled study [abstract]. Hepatology 2004; 40: 272A.
  • 47
    Tran TT, Keeffe EB. Management of the pregnant hepatitis B patient. Curr Hep B Rep 2008; 2: 438.
  • 48
    Wong VC, Lee AKY, Ip HMH. Transmission of hepatitis B antigens from symptom free carrier mothers to the fetus and the infant. Br J Obstet Gynaecol 1980; 87: 95865.
  • 49
    Lee AK, Ip HM, Wong VC. Mechanisms of maternal–fetal transmission of hepatitis B virus. J Infect Dis 1978; 138: 66871.
  • 50
    Beasley RP, Stevens CE, Shiao IS, Meng HC, et al. Evidence against breastfeeding as a mechanism for vertical transmission of hepatitis B. Lancet 1975; 2: 7401.
  • 51
    De Martino M, Appendino C, Resti M, et al. Should hepatitis B surface antigen positive mothers breast feed? Arch Dis Child 1985; 60: 9724.
  • 52
    Hill JB, Sheffield JS, Kim MJ, et al. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002; 99: 104952.
  • 53
    Gartner LM, Morton J, Lawrence RA, et al. American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2005; 115: 496506.
  • 54
    Wang JS, Zhu QR, Wang XH. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. Int J Clin Pract 2003; 57: 1002.